The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Year-to-year changes in lung function in individuals with cystic fibrosis
Abstract
Background We examined the year-to-year change in FEV1 for individuals and the overall cystic fibrosis population to better understand how individual trends may differ from population trends. Methods We calculated individual yearly changes using the largest annual FEV1 percent predicted (FEV1%) measurement in 20,644 patients (6–45 years old) included in the Epidemiologic Study of Cystic Fibrosis. We calculated yearly population changes using age-specific medians. Results FEV1% predicted decreased 1–3 points per year for individuals, with maximal decreases in 14–15 year olds. Population changes agreed with individual changes up to age 15; however after age 30, yearly population change approximated zero while individual FEV1% predicted decreases were 1–2 points per year. Conclusions Adolescents have the greatest FEV1% predicted decreases; however. loss of FEV1 is a persistent risk in 6–45 year old CF patients. Recognizing individual year-to-year changes may improve patient-specific care and may suggest new methods for measuring program quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Progressive lung function decline is a hallmark of cystic fibrosis (CF), with most patients experiencing a decline in percent predicted forced expiratory volume in 1 second (ppFEV 1 ) of 1 to 3 percentage points annually [1] .”
From EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS (2023) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
SHWACHMAN, H. (1958) · A.M.A. Journal of Diseases of Children · doi:10.1001/archpedi.1958.02060060008002 · Cited by 994
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Self-citationReference Ranges for Spirometry Across All Ages: A New Approach
Stanojevic, S., Wade, A., Stocks, J., Hankinson, J., Coates, A. L., Pan, H., Rosenthal, M., Corey, M., Lebecque, P., & Cole, T. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1248oc · Cited by 699
Pulmonary function between 6 and 18 years of age
Wang, X., Dockery, D. W., Wypij, D., Fay, M. E., & Ferris, B. G. (1993) · Pediatric Pulmonology · doi:10.1002/ppul.1950150204 · Cited by 648
Martínez-García, M. A., Soler-Cataluña, J.-J., Perpiñá-Tordera, M., Román-Sánchez, P., & Soriano, J. (2007) · Chest · doi:10.1378/chest.07-0490 · Cited by 483
Konstan, M. W., Morgan, W. J., Butler, S. M., Pasta, D. J., Craib, M. L., Silva, S. J., Stokes, D. C., Wohl, M. E. B., Wagener, J. S., Regelmann, W. E., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.006 · Cited by 438
Self-citationQuality-of-Life Assessment: Can We Keep It Simple?
Cox, D. R., Fitzpatrick, R., Fletcher, A. E., Gore, S. M., Spiegelhalter, D. J., & Jones, D. R. (1992) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982889 · Cited by 349
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., & Boyle, M. P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-327oc · Cited by 319
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
Corey, M., Edwards, L., Levison, H., & Knowles, M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70025-8 · Cited by 283
A new prognostic score and clinical evaluation system for cystic fibrosis
Taussig, L. M., Kattwinkel, J., Friedewald, W. T., & di Sant'Agnese, P. A. (1973) · The Journal of Pediatrics · doi:10.1016/s0022-3476(73)80110-6 · Cited by 265
Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis
Mayer-Hamblett, N., Aitken, M. L., Accurso, F. J., Kronmal, R. A., Konstan, M. W., Burns, J. L., Sagel, S. D., & Ramsey, B. W. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1354oc · Cited by 226
Self-citationFactors Influencing Outcomes in Cystic Fibrosis
Johnson, C., Butler, S. M., Konstan, M. W., Morgan, W., & Wohl, M. E. B. (2003) · Chest · doi:10.1378/chest.123.1.20 · Cited by 225
Self-citationMorgan, W. J., Butler, S. M., Johnson, C. A., Colin, A. A., FitzSimmons, S. C., Geller, D. E., Konstan, M. W., Light, M. J., Rabin, H. R., Regelmann, W. E., et al. (1999) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199910)28:4<231::aid-ppul1>3.0.co;2-2 · Cited by 182
Self-citationLung function decline and outcomes in an elderly population
Mannino, D. M. (2006) · Thorax · doi:10.1136/thx.2005.052449 · Cited by 180
Augmentation Therapy for α1Antitrypsin Deficiency: A Meta-Analysis
Chapman, K. R., Stockley, R. A., Dawkins, C., Wilkes, M. M., & Navickis, R. J. (2009) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902905961 · Cited by 171
Lung Function Decline in Cystic Fibrosis Patients and Timing for Lung Transplantation Referral
Rosenbluth, D., Wilson, K., Ferkol, T. W., & Schuster, D. P. (2004) · CHEST Journal · doi:10.1378/chest.126.2.412 · Cited by 153
Lung Function Decline and Outcomes in an Adult Population
Mannino, D. M., Reichert, M. M., & Davis, K. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1344oc · Cited by 152
Noncomparability of Longitudinally and Cross-sectionally Determined Annual Change in Spirometry
Glindmeyer, H. W., Diem, J. E., Jones, R. N., & Weill, H. (1982) · American Review of Respiratory Disease · doi:10.1164/arrd.1982.125.5.544 · Cited by 121
SCHLUCHTER, M. D., Konstan, M. W., & Davis, P. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1104 · Cited by 110
Self-citationPeat, J. K., Woolcock, A. J., & Cullen, K. K. (1990) · Thorax · doi:10.1136/thx.45.1.32 · Cited by 97
Airway inflammation and lung function decline in childhood post‐infectious bronchiolitis obliterans
Cazzato, S., Poletti, V. E., Bernardi, F., Loroni, L., Bertelli, L., Colonna, S., ZAPPULLA, F., Timoncini, G., & Cicognani, A. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20784 · Cited by 93
Disease-specific Reference Equations for Lung Function in Patients with Cystic Fibrosis
Kulich, M., Rosenfeld, M., Campbell, J. D., Kronmal, R., Gibson, R. L., Goss, C. H., & Ramsey, B. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1335oc · Cited by 72
Respiratory status in dairy farmers in France; cross sectional and longitudinal analyses
Chaudemanche, H., Monnet, É., Westeel, V., Pernet, D., Dubiez, A., Perrin, C., Laplante, J. J., Depierre, A., & Dalphin, J.-C. (2003) · Occupational and Environmental Medicine · doi:10.1136/oem.60.11.858 · Cited by 52
The role of concomitant respiratory diseases on the rate of decline in FEV1among adult asthmatics
Sherrill, D., Guerra, S., Bobadilla, A., & Barbee, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00017103 · Cited by 33
Chronic Obstructive Lung Disease
Burrows, B., & Earle, R. H. (1969) · New England Journal of Medicine · doi:10.1056/nejm196905222802118 · Cited by 14
Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD
Stanbrook, M. B. (2009) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.14.2.42 · Cited by 10
Association of Cytokine Gene Polymorphisms With Rate of Decline in Lung Function
Yücesoy, B., Kurzius‐Spencer, M., Johnson, V. J., Fluharty, K. L., Kashon, M. L., Guerra, S., Luster, M. I., & Burgess, J. L. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31816515e1 · Cited by 9
Quanjer, P. H. (1992) · Thorax · doi:10.1136/thx.47.6.484 · Cited by 6
Testing Lung Function Decline to Time Lung Transplantation
Liou, T. G., Adler, F. R., & Cahill, B. C. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)37999-x · Cited by 5
Self-citationJavadpour, S., Jones, A. M., & Brownlee, K. G. (2007) · PubMed · Cited by 3
Stanbrook, M. B. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-02007 · Cited by 2
Cited by
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622
Self-citationTezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Taylor-Cousar, J. L., Munck, A., McKone, E. F., van der Ent, C. K., Moeller, A., Simard, C., Wang, L. T., Ingenito, E. P., McKee, C., Lu, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709846 · Cited by 794
Cystic fibrosis in the year 2020: A disease with a new face
De Boeck, K. (2020) · Acta Paediatrica · doi:10.1111/apa.15155 · Cited by 332
Ratjen, F., Hug, C., Marigowda, G., Tian, S., Huang, X., Stanojevic, S., Milla, C. E., Robinson, P. D., Waltz, D., Davies, J. C., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30215-1 · Cited by 294
Lung function decline from adolescence to young adulthood in cystic fibrosis
VandenBranden, S. L., McMullen, A., Schechter, M. S., Pasta, D. J., Michaelis, R. L., Konstan, M. W., Wagener, J. S., Morgan, W. J., McColley, S. A., & for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (2012) · Pediatric Pulmonology · doi:10.1002/ppul.21526 · Cited by 128
Self-citation
Metadata
- Authors
- Liou, T. G., Elkin, E. P., Pasta, D. J., Jacobs, J. R., Konstan, M. W., Morgan, W. J., & Wagener, J. S.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 9
- Issue
- 4
- Pages
- 250-256
- ISSN
- 1569-1993
- PMC
- PMC4102928
- Cited by
- 110
- References
- 33
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1148 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.